article thumbnail

Adderall Shortage Drives Shift to Alternative ADHD Medications in Children

PharmExec

Prescription data between 2017 and 2023 revealed that while Adderall prescription fills decreased following the shortage, many children transitioned to alternative stimulants for attention-deficit/hyperactivity disorder.

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

The FDA Law Blog

A red flag does not prohibit a pharmacist from filling a prescription but is a potential concern with the prescription that the pharmacist must address and resolve. If the pharmacist can resolve it, they must make a record of the resolution. Complaint ΒΆ 55.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. 10 Since FDA approval in 1998 the β€˜Little Blue Pill’ had some of the fastest prescription uptakes and sales growth of any medication, bringing in $400 million in revenue in its first quarter after launch and going on to produce annual sales of about $1.8

article thumbnail

Healthcare communication and how it’s changing

pharmaphorum

Hutnik shared a story from her experience where tracking community adoption of a therapy helped them to target more receptive communities, leading to prescription fills almost eight times higher. And I think this is well doable now.”. Advice for communicators.

article thumbnail

Breztri savings tips

The Checkup by Singlecare

From 2017 to 2020, the hospitalization rate for people with chronic obstructive pulmonary disease (COPD) dropped significantly , from 233.6 Calling around before you get your prescription filled could lead to significant savings. per 100,000 cases to just 101.3.

article thumbnail

Ozempic statistics 2025

The Checkup by Singlecare

Ozempic was approved by the Food and Drug Administration (FDA) in 2017 for the treatment of Type 2 diabetes. Out of the total number of Ozempic prescriptions filled, this amounts to about 6,732. However, this number is lower for adults over 65: Only 1% of these users have taken a GLP-1 for weight loss alone.